Literature DB >> 35090584

Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQβ1.

Ana Valencia1, Candelaria Vergara2, Chloe L Thio3, Nicolas Vince4, Venceslas Douillard4, Alba Grifoni5, Andrea L Cox3, Eric O Johnson6, Alex H Kral6, James J Goedert7, Alessandra Mangia8, Valeria Piazzolla8, Shruti H Mehta2, Gregory D Kirk9, Arthur Y Kim10, Georg M Lauer11, Raymond T Chung11, Jennifer C Price12, Salim I Khakoo13, Laurent Alric14, Matthew E Cramp15, Sharyne M Donfield16, Brian R Edlin17, Michael P Busch18, Graeme Alexander19, Hugo R Rosen20, Edward L Murphy18, Genevieve L Wojcik2, Mary Carrington21, Pierre-Antoine Gourraud4, Alessandro Sette22, David L Thomas3, Priya Duggal23.   

Abstract

Spontaneous clearance of acute hepatitis C virus (HCV) infection is associated with single nucleotide polymorphisms (SNPs) on the MHC class II. We fine-mapped the MHC region in European (n = 1,600; 594 HCV clearance/1,006 HCV persistence) and African (n = 1,869; 340 HCV clearance/1,529 HCV persistence) ancestry individuals and evaluated HCV peptide binding affinity of classical alleles. In both populations, HLA-DQβ1Leu26 (p valueMeta = 1.24 × 10-14) located in pocket 4 was negatively associated with HCV spontaneous clearance and HLA-DQβ1Pro55 (p valueMeta = 8.23 × 10-11) located in the peptide binding region was positively associated, independently of HLA-DQβ1Leu26. These two amino acids are not in linkage disequilibrium (r2 < 0.1) and explain the SNPs and classical allele associations represented by rs2647011, rs9274711, HLA-DQB1∗03:01, and HLA-DRB1∗01:01. Additionally, HCV persistence classical alleles tagged by HLA-DQβ1Leu26 had fewer HCV binding epitopes and lower predicted binding affinities compared to clearance alleles (geometric mean of combined IC50 nM of persistence versus clearance; 2,321 nM versus 761.7 nM, p value = 1.35 × 10-38). In summary, MHC class II fine-mapping revealed key amino acids in HLA-DQβ1 explaining allelic and SNP associations with HCV outcomes. This mechanistic advance in understanding of natural recovery and immunogenetics of HCV might set the stage for much needed enhancement and design of vaccine to promote spontaneous clearance of HCV infection.
Copyright © 2022. Published by Elsevier Inc.

Entities:  

Keywords:  GWAS; HCV clearance; HLA imputation; HLA-DQβ1; MHC; fine-mapping; hepatitis C virus; host genetics; infection; trans-ancestral

Mesh:

Substances:

Year:  2022        PMID: 35090584      PMCID: PMC8874224          DOI: 10.1016/j.ajhg.2022.01.001

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.043


  66 in total

1.  Principal components analysis corrects for stratification in genome-wide association studies.

Authors:  Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich
Journal:  Nat Genet       Date:  2006-07-23       Impact factor: 38.330

2.  Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma).

Authors:  J D Reveille; D Owerbach; R Goldstein; R Moreda; R A Isern; F C Arnett
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

3.  Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus.

Authors:  Peter V Aka; Mark H Kuniholm; Ruth M Pfeiffer; Alan S Wang; Wei Tang; Sabrina Chen; Jacquie Astemborski; Michael Plankey; Maria C Villacres; Marion G Peters; Seema Desai; Eric C Seaberg; Brian R Edlin; Howard D Strickler; David L Thomas; Ludmila Prokunina-Olsson; Gerald B Sharp; Thomas R O'Brien
Journal:  J Infect Dis       Date:  2013-08-15       Impact factor: 5.226

4.  HLA class II favors clearance of HCV infection and progression of the chronic liver damage.

Authors:  A Mangia; R Gentile; I Cascavilla; M Margaglione; M R Villani; F Stella; G Modola; V Agostiano; C Gaudiano; A Andriulli
Journal:  J Hepatol       Date:  1999-06       Impact factor: 25.083

5.  Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source.

Authors:  Susan M McKiernan; Richard Hagan; Michael Curry; George S A McDonald; Alan Kelly; Niamh Nolan; Anne Walsh; John Hegarty; Emer Lawlor; Dermot Kelleher
Journal:  Hepatology       Date:  2004-07       Impact factor: 17.425

6.  Construction and benchmarking of a multi-ethnic reference panel for the imputation of HLA class I and II alleles.

Authors:  Frauke Degenhardt; Mareike Wendorff; Michael Wittig; Eva Ellinghaus; Lisa W Datta; John Schembri; Siew C Ng; Elisa Rosati; Matthias Hübenthal; David Ellinghaus; Eun Suk Jung; Wolfgang Lieb; Shifteh Abedian; Reza Malekzadeh; Jae Hee Cheon; Pierre Ellul; Ajit Sood; Vandana Midha; B K Thelma; Sunny H Wong; Stefan Schreiber; Keiko Yamazaki; Michiaki Kubo; Gabrielle Boucher; John D Rioux; Tobias L Lenz; Steven R Brant; Andre Franke
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

7.  IEDB-AR: immune epitope database-analysis resource in 2019.

Authors:  Sandeep Kumar Dhanda; Swapnil Mahajan; Sinu Paul; Zhen Yan; Haeuk Kim; Martin Closter Jespersen; Vanessa Jurtz; Massimo Andreatta; Jason A Greenbaum; Paolo Marcatili; Alessandro Sette; Morten Nielsen; Bjoern Peters
Journal:  Nucleic Acids Res       Date:  2019-07-02       Impact factor: 16.971

8.  Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.

Authors:  Priya Duggal; Chloe L Thio; Genevieve L Wojcik; James J Goedert; Alessandra Mangia; Rachel Latanich; Arthur Y Kim; Georg M Lauer; Raymond T Chung; Marion G Peters; Gregory D Kirk; Shruti H Mehta; Andrea L Cox; Salim I Khakoo; Laurent Alric; Matthew E Cramp; Sharyne M Donfield; Brian R Edlin; Leslie H Tobler; Michael P Busch; Graeme Alexander; Hugo R Rosen; Xiaojiang Gao; Mohamed Abdel-Hamid; Richard Apps; Mary Carrington; David L Thomas
Journal:  Ann Intern Med       Date:  2013-02-19       Impact factor: 25.391

9.  IPD-IMGT/HLA Database.

Authors:  James Robinson; Dominic J Barker; Xenia Georgiou; Michael A Cooper; Paul Flicek; Steven G E Marsh
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

10.  Genetic Association Reveals Protection against Recurrence of Clostridium difficile Infection with Bezlotoxumab Treatment.

Authors:  Judong Shen; Devan V Mehrotra; Mary Beth Dorr; Zhen Zeng; Junhua Li; Xun Xu; David Nickle; Emily R Holzinger; Aparna Chhibber; Mark H Wilcox; Rebecca L Blanchard; Peter M Shaw
Journal:  mSphere       Date:  2020-05-06       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.